| Investor Type | Firm |
| Type of Fund | Other |
| Investing | Singapore |
BioPath Ventures is an investment fund that focuses on the Life Science Tools and Diagnostics sectors. They aim to identify and foster the growth of emerging opportunities within these fields that have the potential to make a global market impact.
BioPath Ventures not only seeks to financially back companies but also looks to create a conducive business ecosystem that can support the growth and progression of these companies, benefiting the clients and the wider community in the process. They hold a strong mission of developing life science tools and diagnostics ventures that are poised for success and innovation.
Armed with industry expertise, BioPath Ventures leverages the extensive experience of partners like Nicolas H. Roelofs, Ph.D., who has a significant background in life sciences and diagnostics, and Joseph Jeong, an expert in venture capital investments within the technology and biotech sectors, particularly in Southeast Asia.
Dr. Roelofs' experience spans multiple start-ups and multinational corporations, while Dr.
Jeong has a history with investments and engineering within leading companies and research on advanced technologies such as lithium-ion batteries and fuel cells. BioPath Ventures sets itself apart by combining the scientific, operational, and investment expertise of its partners to give their portfolio companies an edge in the competitive life sciences arena.
The firm operates out of Millbrae, California, and engages with a variety of stakeholders, including governments and investors, to support innovation and growth in their specialized segments of the market.









